Aging Pet Population Is ‘Solid Longer-Term Tailwind’ For IDEXX Labs: Analyst
IDEXX Laboratories reports Q1 EPS of $2.81 (up 10% Y/Y), with sales reaching $964M (7% increase). Revenue growth driven by Companion Animal Group and Water segments. Operating margin at 31.0%.